{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:40:03Z","timestamp":1770972003665,"version":"3.50.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[1992,8,1]],"date-time":"1992-08-01T00:00:00Z","timestamp":712627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1992,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The present study aimed to establish the role of the metabolite norfluoxetine in the anorectic activity of fluoxetine, and to relate the anorectic doses (ED50) to the brain concentrations of the parent drug and its metabolite. Fluoxetine showed anorectic activity at increasing intraperitoneal doses (ED50 = 391, 34\u00b77 and 21\u00b77 \u03bcmol kg\u22121 in mouse, rat and guinea-pig, respectively) and norfluoxetine was slightly more active (24\u00b73, 22\u00b79 and 19\u00b71 \u03bcmol kg\u22121, respectively) in all three species. In terms of maximum concentration (Cmax) and area under the curve (AUC) within the experimental period (0\u201390 min), brain concentrations varied widely and were poorly related to the dose; guinea-pig appeared to be much more sensitive to fluoxetine than was mouse or rat. Administered norfluoxetine was present in the brain of the three species in approximately the same order as fluoxetine, i.e. lower in guinea-pig than in mouse or rat. The Cmax and AUC of norfluoxetine after fluoxetine administration was 50\u201360% of the values after an equiactive dose of norfluoxetine in mouse and guinea-pig, and more than 80% in rat.<\/jats:p>","DOI":"10.1111\/j.2042-7158.1992.tb05500.x","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T20:45:50Z","timestamp":1302641150000},"page":"696-698","source":"Crossref","is-referenced-by-count":35,"title":["Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs"],"prefix":"10.1093","volume":"44","author":[{"given":"M","family":"Anelli","sequence":"first","affiliation":[{"name":"Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d , via Eritrea 62, 20157 Milan,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Bizzi","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d , via Eritrea 62, 20157 Milan,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Caccia","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d , via Eritrea 62, 20157 Milan,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Codegoni","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d , via Eritrea 62, 20157 Milan,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Fracasso","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d , via Eritrea 62, 20157 Milan,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Garattini","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d , via Eritrea 62, 20157 Milan,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1992,8,1]]},"reference":[{"key":"2024103110453578800_cit1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00003495-198632060-00002","article-title":"Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.","volume":"32","author":"Benfield","year":"1986","journal-title":"Drugs"},{"issue":"Suppl. 3","key":"2024103110453578800_cit2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1192\/S0007125000297286","article-title":"Clinical pharmacology and pharmacokinetics of fluoxetine: a review.","volume":"153","author":"Bergstrom","year":"1988","journal-title":"Br. J. Psychiatry"},{"key":"2024103110453578800_cit3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.2042-7158.1992.tb03592.x","article-title":"Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms.","volume":"44","author":"Caccia","year":"1992","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110453578800_cit4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF02244004","article-title":"Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat.","volume":"100","author":"Caccia","year":"1990","journal-title":"Psychopharmacology"},{"key":"2024103110453578800_cit5","first-page":"E97","article-title":"Simultaneous analysis of families sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.","volume":"235","author":"De Lean","year":"1978","journal-title":"Am. J. Physiol."},{"issue":"Suppl. 3","key":"2024103110453578800_cit6","first-page":"163","article-title":"Fluoxetine-induced weight loss in overweight non-depressed humans.","volume":"11","author":"Ferguson","year":"1987","journal-title":"Int. J. Obes."},{"issue":"Suppl.","key":"2024103110453578800_cit7","first-page":"124","article-title":"Drug treatment for bulimia and bulimia nervosa.","volume":"96","author":"Freeman","year":"1988","journal-title":"Psychopharmacology"},{"key":"2024103110453578800_cit8","first-page":"227","article-title":"Progress report on drugs inducing anorexia by affecting brain serotonin","volume-title":"Obesity and Cachexia","author":"Garattini","year":"1991"},{"key":"2024103110453578800_cit9","first-page":"1","article-title":"Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with 3H-serotonin.","volume":"345","author":"Gobbi","year":"1992","journal-title":"Naunyn Schmiede-bergs Arch. Pharmacol."},{"key":"2024103110453578800_cit10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.2042-7158.1976.tb04165.x","article-title":"Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding.","volume":"28","author":"Goudie","year":"1976","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103110453578800_cit11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1749-6632.1987.tb36219.x","article-title":"Pharmacological treatments that affect CNS activity: serotonin.","volume":"499","author":"Nathan","year":"1987","journal-title":"Ann. NY Acad. Sci."},{"key":"2024103110453578800_cit12","first-page":"560","article-title":"In vivo demethylation of Lilly 110140: 3(p-TRI-fluoromethylphenoxy)-N-methyl-3-phenylpropylamine to an active metabolite-Lilly 103947.","volume":"33","author":"Parli","year":"1974","journal-title":"Fed. Proc."},{"key":"2024103110453578800_cit13","first-page":"163","article-title":"The pharmacology of serotoninergic drugs affecting appetite","volume-title":"Nutrition and the Brain","author":"Samanin","year":"1990"},{"issue":"Suppl. 2","key":"2024103110453578800_cit14","first-page":"125","article-title":"Serotonergic mechanisms in feeding","author":"Wong","year":"1987","journal-title":"Int. J. Obes."},{"key":"2024103110453578800_cit15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0091-3057(88)90376-0","article-title":"Suppression of food intake in rats by fluoxetine: comparison of enantiomers and effects of serotonin antagonists.","volume":"31","author":"Wong","year":"1988","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7158.1992.tb05500.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/44\/8\/696\/60270497\/j.2042-7158.1992.tb05500.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/44\/8\/696\/60270497\/j.2042-7158.1992.tb05500.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T11:25:03Z","timestamp":1730373903000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/44\/8\/696\/6163584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,8,1]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[1992,8,1]]},"published-print":{"date-parts":[[1992,8,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7158.1992.tb05500.x","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"value":"2042-7158","type":"electronic"},{"value":"0022-3573","type":"print"}],"subject":[],"published-other":{"date-parts":[[1992,8]]},"published":{"date-parts":[[1992,8,1]]}}}